Michael Hillman, DO
Family Medicine · Post Falls, IDNPI 1740867753
Payments from drug & device makers
Across 18 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$116
- Dexcom, Inc.$41
- Novo Nordisk$34
- Daiichi Sankyo Inc.$29
- Otsuka America Pharmaceutical, Inc.$26
- Corcept Therapeutics$20
- plus $97 from 6 others
What the payments were for
- Food & beverage$363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 5 | $116 |
| Dexcom, Inc. | 2 | $41 |
| Novo Nordisk | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
How this compares
$363 in reported general payments places this provider in the 55th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 30 | $848 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $777 |
| Duloxetine Hcl | 20 | $555 |
| Levothyroxine Sodium | 33 | $425 |
| Gabapentin | 18 | $305 |
| Atorvastatin Calcium | 35 | $294 |
| Famotidine | 20 | $287 |
| Lisinopril | 29 | $205 |
| Metformin Hcl | 30 | $174 |
| Finasteride | 15 | $166 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $159 |
| Fluticasone Propionate | 12 | $145 |
| Sertraline Hcl | 26 | $135 |
| Omeprazole | 14 | $117 |
| Trazodone Hcl | 11 | $112 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Post Falls
- Michael MonohanPost Falls$8K
- Morgan FordPost Falls$8K
- Anthony PetersPost Falls$6K
- Chad ScarolaPost Falls$6K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.